Search Results 1201-1210 of 19336 for Hemoglobin

1. PKCι & mTOR Inhibition With Auranofin+Sirolimus for Squamous Cell Lung Cancer - Mayo Clinic

   Hemoglobin (Hgb) ≥ 9 g/dL; Total bilirubin ≤ 1.5 x upper limit of normal (ULN) or direct bilirubin ≤ ULN; Serum glutamic oxaloacetic transaminase (SGOT) ...

2. Study Evaluating ABT-199 in Subjects With Relapsed or Refractory Multiple Myeloma - Mayo Clinic

   Hemoglobin ≥8.0 g/dL, subjects may receive blood transfusion to achieve hemoglobin eligibility criteria per investigator discretion. Total bilirubin ≤1.5 ...

3. Sorafenib for Hepatopulmonary Syndrome - Mayo Clinic

   Presence of cirrhosis/hepatic fibrosis and/or portal hypertension. Child-Pugh class A or B liver disease; Platelet count ≥ 30 ×10e9 per liter; Hemoglobin ≥ ...

4. Randomized Phase II/III Trial of Adjuvant Radiation Therapy with Cisplatin, Docetaxel-Cetuximab, or Cisplatin-Atezolizumab in Pathologic High-Risk Squamous Cell Cancer of the Head and Neck - Mayo Clinic

   Hemoglobin ≥ 8.0 g/dl (Note: The use of transfusion or other intervention to achieve hemoglobin [Hgb] ≥ 8.0 g/dl is acceptable); Total bilirubin < 2 x ...

5. Pilot Study of Rituximab to Treat Fibrillary Glomerulonephritis - Mayo Clinic

   Hemoglobin >7.0 gm/dL, white count >3.0 X 10(9), platelet count >100 X 10(9). Exclusion Criteria: History of HIV; Presence of active infection; New York Hear ...

6. Carfilzomib and Dexamethasone in Treating Patients With Multiple Myeloma Who Previously Underwent a Stem Cell Transplant - Mayo Clinic

   Hemoglobin ≥ 8.0 g/dL; Previous diagnosis of symptomatic multiple myeloma (MM); Received single autologous stem cell transplantation 60-120 days prior to ...

7. A Multicenter Phase I Study of MRX34, MicroRNA miR-RX34 Liposomal Injection - Mayo Clinic

   Hemoglobin ≥ 9 g/dL; For the hematologic malignancy patients, blood count values cited above do not apply. Prothrombin time (PT) or International Normalized ...

8. A Trial of ZL-1201 in Subjects with Advanced Cancer - Mayo Clinic

   Hemoglobin ≥ 10 g/dL without transfusion in the 2 weeks prior to screening. Prothrombin time, international normalized ratio or activated partial ...

9. Testing The Addition Of High Dose, Targeted Radiation To The Usual Treatment For Locally-Advanced Inoperable Non-small Cell Lung Cancer - Mayo Clinic

   - Hematologic function (e.g. platelets, leukocytes, hemoglobin) amenable, at the discretion of the treating physician, to allow for treatment with ...

10. Study of Determine the Safety and Effectiveness of SHP647 as Maintenance Therapy in Subjects with Moderate-to-Severe Crohn's Disease - Mayo Clinic

    Hemoglobin level ≤ 80 g/L (8.0 g/dL);; Platelet count ≤ 100 × 109/L (100,000 cells/mm^3) or ≥ 1000 × 109/L (1,000,000 cells/mm^3)*;; White blood cell count ...